PTGS2 and rheumatoid arthritis: As shown in Figure 5E, PTGS2, MMP9, JUN, HIF1A, ESR1, EGFR, MMP2, and GSK3B consistently stood out in all three centrality networks, qualifying them as hub genes for XFC’s treatment of RA.